Pharmaceutical and biotech companies are evaluating development and manufacturing strategies against a changing funding environment, evolving supply-chain requirements, and increasing demand for manufacturing capacity in the United States. These factors are influencing how sponsors approach API development and CDMO partnerships and where they turn for the technical expertise required to advance programs toward commercialization.
Olon USA will join Olon at CPHI Milan 2026, taking place October 6–8 at Fiera Milano in Italy. Olon USA representatives will be available at Stand 6H2 in the Contract Manufacturing and Services Zone to discuss development and manufacturing programs with pharmaceutical and biotech companies.
The Olon USA team attending CPHI Milan will include CEO Robert Poe, Laura Milbrandt, Tim Morgan, Lael Chung, Sharmila Khambit, Mrinali Arora, and Nur Mansour. The team will host meetings with companies evaluating purchases from Olon’s catalog of generic APIs, API development, scale-up, manufacturing, and broader CDMO requirements.
API Development and Manufacturing Requirements Are Changing
Funding remains a significant consideration for companies advancing drug candidates, particularly during the earlier stages of development. Programs in Phase II and Phase III are attracting more funding opportunities, while earlier-stage companies continue to navigate a more constrained environment.
At the same time, pharmaceutical companies are evaluating where and how their products are manufactured. Reshoring initiatives, geopolitical considerations, and the need for greater supply-chain resilience are increasing interest in U.S.-based manufacturing capabilities.
These factors create different requirements depending on where a program sits in development. Early-stage programs may require process development, synthetic chemistry, and analytical support. Later-stage programs require reliable scale-up and manufacturing capabilities capable of supporting clinical and commercial requirements.
A CDMO partner needs to understand those requirements and provide the technical resources necessary to move a program forward.
Connecting Development Expertise with Manufacturing
Olon USA provides contract research, development and manufacturing services for chemical-based industries, with capabilities spanning analytical chemistry, synthetic chemistry, process chemistry, engineering and manufacturing. Its small-molecule focus supports projects from development and scale-up through larger-scale manufacturing.
That integrated approach is particularly relevant for sponsors moving a synthetic process from an external development environment into scale-up and manufacturing.
Olon USA’s Concord, Ohio team has experience optimizing and scaling synthetic processes developed internationally, helping sponsors meet the technical requirements of bringing processes into U.S. operations. The site provides a single integrated location for chemical development, analytical chemistry, engineering, and manufacturing activities.
The broader Olon network adds another layer of technical resources. When a project requires specialized chemistry, Olon USA can draw on expertise across Olon’s global R&D and manufacturing organization. Capabilities such as biocatalysis, flow chemistry and other specialized approaches can be evaluated as part of developing an appropriate pathway for the program.
U.S. Manufacturing Capacity Supports Reshoring Strategies
Interest in U.S. pharmaceutical manufacturing has increased as companies evaluate supply-chain risk and geographic diversification.
Olon has expanded its U.S. manufacturing capabilities to support mid-scale commercial manufacturing in the United States. Olon USA’s Concord, Ohio operations provide an opportunity for sponsors to evaluate U.S.-based manufacturing within the broader Olon network.
The site also provides opportunities for additional capacity expansion as market requirements evolve.
For European and other international pharmaceutical companies seeking U.S. manufacturing capabilities, this creates an opportunity to evaluate development and manufacturing strategies with a global CDMO that can support programs across multiple stages.
Supporting Programs from Development Through Commercial Manufacturing
Olon’s global capabilities extend across development and commercial manufacturing, allowing sponsors to engage technical resources based on the requirements of a specific program.
For late-stage Phase III and commercial programs, Olon’s global manufacturing experience provides access to established manufacturing capabilities and technical expertise. For programs that require additional process development work, Olon USA can provide chemical development, synthetic chemistry, analytical chemistry, and scale-up support.
The ability to connect these capabilities across the Olon organization can help sponsors identify the appropriate technical and manufacturing resources as their programs progress.
This is particularly important for companies managing complex molecules or processes that require specialized expertise. Olon’s global network of scientific resources includes centers of excellence that can support different technologies and development requirements, giving sponsors access to resources beyond a single manufacturing site.
CPHI Milan Creates an Opportunity for Direct Technical Discussions
CPHI Milan brings pharmaceutical companies, CDMOs, and other participants across the global pharmaceutical supply chain together in one location. For Olon, the event provides an opportunity to connect its global organization with current and prospective customers.
Olon representatives from its different divisions will be available throughout the event, creating opportunities for companies to discuss programs with experts aligned to their specific development or manufacturing requirements.
Olon will also host opportunities for select CPHI attendees to visit its headquarters near Milan and participate in exclusive events during the conference. Companies interested in touring the facility or attending Olon-hosted events can connect with the Olon USA team in advance to learn more and coordinate participation.
For companies evaluating API development, process optimization, scale-up, U.S. manufacturing, or commercial manufacturing strategies, a meeting at CPHI Milan can provide a starting point for identifying the right Olon capabilities and site for a project.
Meet Olon USA at Stand 6H2
Olon USA will be exhibiting with Olon at Stand 6H2 in the Contract Manufacturing and Services Zone at CPHI Milan, October 6–8, 2026.
The Olon team will be available to discuss a wide range of programs, including small molecules, fermentation, antibody-drug conjugates, and other projects requiring specialized development or manufacturing expertise. Discussions can focus on current technical challenges, development requirements, scale-up needs, U.S. manufacturing strategies, or commercial manufacturing opportunities.
Companies attending CPHI Milan can contact Olon USA to schedule a meeting at Stand 6H2 and begin a discussion about the technical, development, and manufacturing requirements of their next project. Connecting with the Olon USA team can help identify the appropriate capabilities within the broader Olon network and establish a path forward for the program.